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Using enrichment techniques, Waksman and Woodruff 
(1940), isolated from soil a species of actinomycetes. 
They found the ether soluble fraction of the culture fil-
trate to be inhibitory towards growth of select organisms. 
The ether soluble compound was named actinomycin. Waksman 
(1954) investigated the antibiotic's spectrum of activity. 
It was found to be highly active against gram positive bac-
teria and actinomycetes, with less activity towards gram-
negative bacteria and no activity upon fungi. The crystal-
lized compound was brick red in color with a melting tem-
perature of approximately 250°c, it absorbed light at 230, 
250, and 450 nm, and the molecular weight was 1255· 
Manaker, et al. (1955) crystallized actinomycin D from 
cultures of Streptomyces parvullus by both solvent (ether) 
and charcoal adsorption procedures. The molecular formula 
of the crystalline compound was determined to be c60H76o15 
N12 ·JH2o and the molecule contained a chromophoric moiety 
with two peptide chains linked to it. The peptide chains 
each contained the amino acids sarcosine, D-valine, L-pro-
line, L-threonine, and N-methyl-valine (Fig. 1). 
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Figure 1. Structure of Actinomycin D. The functional 
groups of the actinomycin molecule are the 
free chromophore amino groups, the unreduced 
quinoidal ring system, and the lactone rings. 
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Toxicity of actinomycin was shown in mice, rats, and 
rabbits by Robinson and Waksman (1942). Doses as small as 
1 mg per kilogram of body weight were lethal in the test 
animals. Actinomycin injected intravenously rapidly left 
the blood stream and could be found in various quantities· 
throughout all organs of the test animals. Pugh, Katz, and 
Waksman (1956) demonstrated the antitumor potential of the 
actinomycins in laboratory animals. However, they found 
the drug had a high toxicity in the test animals, with a 
marked decrease in spleen size occurring in many cases. 
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Actinomycin D is currently used against treatment of 
disseminated neoplasia. It has proven of value against tes-
ticular tumors, trophoblastic malignancies, soft tissue sar-
comas, and Wilm's tumor. Actinomycin D may be the most 
effective agent available for testicular cancer (Livingston 
and Carter, 1970), 
Barnett, Ryman, and Smith (1946a) were the first to 
report antimicrobial activity of azasteroid compounds. 
They found that two isomers of ?-amino-cholesterol showed 
a high antibacterial activity in vitro against gram-pos-
i tive organisms, Barnett, Ryman, and Smith (1946b) also 
reported that mono- and di-cholestane derivatives with nit-
rogen in the 3,6 or 7 position showed antimicrobial activity. 
Chesnut, et al. (1972) demonstrated that ring structures 
containing nitrogen and related compounds exhibit a broad 
spectrum of biological activities which makes them useful 
as therapeutic agents. 
Agents such as detergents, EDTA, and bacteriophage 
have the capability to potentiate the action of actinomycin 
D by altering the permeability barrier of the cell, thus 
enhancing the entry of the antibiotic into the cell (Leive, 
1965; Roy and Mitra, 1970; Reihm and Biedler, 1972), iV1arks 
and Venditte (1976) demonstrated the abilityof DNA, which 
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is the primary site which actinomycin D acts upon in the 
cell, to form a complex with the antibiotic and potentiate 
it's activity while at the same time negate the cytotox-
icity of the drug. Chesnut, et al. (1974) have provided 
proton-magnetic-resonance and ultraviolet spectroscopic evi-
dence which suggests a molecular complex is formed between 
a novel azasteroid and actinomycin D. This complexation of 
the azasteroid with actinomycin D gives much greater biolog-
ical activity against Pseudomonas fluorescens. The new 
azasteroid compound, 10,ll,-dihydro-3H-napth(l,2 g)indazol-
7-ol, was synthesized by Dr. K.D. Berlin and Dr. J.G. lVlor-
gan (Morgan, et al. 1971), The azasteroid, which will be 
referred to as hydroxypyrazole in this thesis, possesses 
antimicrobial activity against a gram-positive bacterium 
Bacillus subtilis but shows no activity against the gram-
negative bacterium Pseudomonas fluorescens. The molecular 
weight of the hydroxypyrazole is 236 with a melting point 
of 257-260°c. The benzene rings constitute a large non-
polar nucleus with the hydroxyl group and two nitrogen 
groups contributing polar properties to the molecule. The 
molecule exhibits absorption peaks in the UV range at 258, 
266, JOO, and 312 nm (Fig. 2). 
Earlier work in this laboratory has shown that select 
aromatic compounds prevent the inhibition of protein syn-
thesis and growth caused by actinomycin D (Durham and Fer-
guson, 1971). Their results indicated that 3,4-dihydroxy-
benzoate (protocatechuate) was the most effective in pre-
venting the inhibition caused by actinomycin D (Fig. 3). 
Actinomycin D prevents protein synthesis by inhibiting 
DNA-directed RNA synthesis. Durham and Keudall (1969) re-
ported that the inhibition of synthesis of amidase (acyl-
amide aminohydrolase, E C 3.5.1.4) by actinomycin D could 
be prevented or alleviated by protocatechuate. It was pro-
posed that protocatechuate complexes with actinomycin D 
to negate the effect of the antibiotic, by preventing the 
interaction of it with cellular DNA. 
This investigation was conducted to investigate the 
biological activity of actinomycin D-hydroxypyrazole com-
plex and the ability of protocatechuate to interact with 
actinomycin D or the complex to negate their biological 
effects. 
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Figure 2. 10,11,-dihydro-JH-napth(l,2 g)indazol-7-ol. 
The molecule has a large non-polar hydroxy 
group attached to the number J carbon and 
polar nitrogens incorporated into the ster-
oid nucleus at the 15 and 16 positions. 
8 
Figure 3. Structure of Protocatechuate. J,4-Dihydroxy-
benzoate has a high potential for hydrogen 






MATERIALS AND METHODS 
Test Organism 
The microorganism used in this study was obtained from 
the stock culture collection of Dr. N.N. Durham, Oklahoma 
State University. This organism was tentatively identified 
by Montgomery (1966) as Pseudomonas fluorescens. This or-
ganism is a gram-negative, motile rod which forms smooth, 
raised colonies on nutrient agar. P. fluorescens exhibits 
a negative reaction for hydrogen sulfide production, indole 
production and nitrate reduction, and produces acid but no 
gas in glucose. The pigments fluorescein and pyocyanin are 
produced when the organism is grown on Bacto-Pseudomonas 
agar F and Bacto-Pseudomonas agar P, respectively. 
Stock cultures of P. fluorescens were maintained on 
slants of succinate-salts synthetic medium, and stored at 
4°c. 
Media 
The synthetic salts medium used in this investigation 
contained1 0.2 percent sodium chloride, 0.2 percent ammon-
ium chloride, 0.32 percent potassium dihydrogen phosphate, 
11 
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o.42 percent dipotassium hydrogen phosphate and 0.2 percent 
of the desired carbon source (succinate, acetamide, or glu-
cose). The pH of the medium was adjusted to 6.8-7.0 with 
KOH prior to sterilization by autoclaving at 121°c with 15 
lbs. pressure per square inch for 15 minutes. After cool-
ing to room temperature, 0.1 ml of a sterile mineral salts 
solution was added to each 100 ml of medium. In studies 
where acetamide was used as the inducer of enzyme synthesis, 
a concentration of 0.08 fv'i was used. Two percent agar (Dif-
eo) was added when a solid medium was required. 
The mineral salts solution used to supplement the me-
dium contained• 5.0 percent 1VlgSo4 •7 H2o, 0,1 percent l\ilnS04 , 
1.0 percent Fec1 3 and 0.5 percent CaC1 2 in distilled deion-
ized water. This solution was then sterilized by autoclav-
ing as described above, and used after the suspension of 
minerals was allowed to settle (Durham, 1958). 
Chemicals 
Actinomycin D was obtained fr.om Merk, Sharp and Dohme 
Research Laboratory, the hydroxypyrazole was provided by 
Dr. K.D. Berlin, Oklahoma State University, and mitomycin C 
was obtained from Sigma Chemical Company. Stock solutions 
of these three compounds were prepared in sterile distilled 
water and stored at 4°c. Protocatechuate (Aldrich Chemical 
Co., Inc.) stock solutions were prepared and filter steril-
ized prior to usage. The concentrations of all chemicals 
used in this study are given in the text. 
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Enzyme Induction 
f. fluorescens cells were grown in succinate-salts 
medium for approximately 12 hours. The cells were harves-
ted by centrifugation (5,900 X g for 10 minutes) and washed 
twice with O.OlM potassium phosphate buffer, pH 7.0 (0.068 
percent potassium dihydrogen phosphate, O.Ob8 percent dipo-
tassium hydrogen phosphate). The washed cells were then 
suspended in 0.01 M phosphate buffer and used to inoculate 
the growth medium (containing succinate plus acetamide), 
and the appropriate combinations of the compounds to be tes-
ted, to an initial O.D. of 0.2 at 540 nm. Samples (0.25 ml) 
were removed at the specified time intervals and immediately 
placed in the freezer (-14°c) for subsequent enzyme deter-
minations. 
Assay Method 
The assay for the determination of enzyme synthesis 
was based on the reaction of acyl phosphates with hydroxyl-
amine at pH 6.5 to 7.0 to form hydroxamic acids (Lipmann 
and Tuttle, 1945). Spectrophotometric procedures can then 
be used to quantitate the hydroxamic acids which will react 
with ferric salts to produce red to violet color complexes. 
Preparatio~ of the Standard Curve 
A hydroxamic acid stock solution was prepared by dis-
solving 0.5 g of succinic anhydride in 20 ml of freshly 
neutralized 2.0 M hydroxylamine hydrochloride. This solu-
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tion was allowed to stand 10 ninutes. Thirty ml of dis-
tilled water was then added to give a final volume of 50 ml. 
One ml of this stock solution was diluted to a final liquid 
volume of 40 ml with distilled water to produce the stand-
ard solution. Two ml of the standard solution was added 
to 1.0 ml of freshly neutralized hydroxylamine hydrochlo-
ride and allowed to stand for 10 minutes. Three ml of fer-
ric chloride (Fec1 3) reagent (6.0 percent w/v in 2.0 percent 
HCl v/v) was added and the absorbance read in a Bausch and 
Lomb Spectronic 70 at 540 nm. The reading obtained from 
this solution was equivalent to 4.o micromoles of acetohy-
droxamic acid. Different dilutions of the stock solution 
were prepared in a total volume of 40 ml to give varying 
concentrations of the acetohydroxamate. The absorbance of 
each dilution was measured, and a standard curve for aceto-
hydroxamate was prepared (Fig. 4). 
Amidase Activity 
The Brammer and Clarke (1964) modification of the Lip-
mann and Tuttle (1945) method for hydroxamic acid determin-
ation was used in this study. This modification is based 
on quantitative determination of acetohydroxamate, which is 
the end product of the translocase reaction of the amidase 
enzyme. The amidase transfers the acyl group of the sub-
strate amides to hydroxylamine to form acylhydroxamates 
(Kelly and Kornberg, 1962). This reaction is shown below. 
Figure 4. Standard curve. Used to determine the micro-
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The substrate mixture was prepared by mixing equal 
volumes of o.4 M acetamide solution, 2.0 iVl freshly neutra-
lized hydroxylamine hydrochloride, and 0.1 M 2-amino-2-
(hydroxymethyl)-1,J-propanediol (tris) buffer (pH 7.2). 
17 
The frozen samples which were taken from the culture flasks 
were thawed and 0.75 ml of the substrate mixture was added 
to each. The tubes were incubated at 37°c for 15 minutes, 
and the reaction was stopped by adding 2.0 ml of Fec1 3 (6.0 
percent w/v in 2.0 percent HCl v/v). The absorbance was 
then read at 540 nm using a Bausch and Lomb Spectronic 70, 
and the amount of acetohydroxamate produced was calculated 
using the standard curve. The specific activity was mea-
sured, and one unit of arnidase was defined as the amount of 
enzyme that would produce one micromole of acetohydroxarnate 
per milligram dry cell weight per 15 minutes. 
Deoxyribonucleic Acid Isolation 
Growth of Cells 
P. fluorescens deoxyribonucleic acid (DNA) was isola-
ted using the Saito and Miura (1963) modification of the 
procedure outlined by Marmur (1961). P. fluorescens cells 
were grown approximately 12 hours on a reciprocal shaker in 
a 2800 ml Fernback flask containing 500 ml of succinate-
salts medium. These cells were then used to inoculate 3 
liters of succinate-salts medium distributed in 6 Fernback 
flasks. The flasks were incubated at 37°c on a reciprocal 
shaker for 5-6 hours before harvesting the cells by centri-
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fugation (8,000 X g for 10 minutes). Usually 12 g of packed 
cells were obtained by this method. The cells were divided 
into two 6 g masses and stored at (-14°c) until needed for 
DNA extraction. 
Extraction of DNA ---
Six grams of packed cells were suspended in 6 ml of 
saline-disodium ethylene diamine tetracetate (EDTA) (0.15 00 
NaCl-0.10 M EDTA). Lysozyme was added giving a final con-
centration of 2 mg/ml. This suspension was then incubated 
at 37°c. After 45 minutes of incubation, 50 ml of tris-SDS 
buffer (0.10 iYJ tris-buffer-1.0 percent SDS-0.10 lYl NaCl, pH 
9,0) was added, followed by the addition of an equal vol-
ume of redistilled phenol saturated with water prior to use. 
This mixture was placed in a glass stoppered round bottom 
flask and shaken for 20 minutes in an ice bath (below 4°c). 
The emulsion was separated into two layers by slow speed 
centrifugation (650 X g for 10 minutes). After the slow 
speed separation, the upper phase was clarified by centri-
fugation (16,JOO X g for 10 minutes) to remove any remain-
ing cell debris. The nucleic acids were precipitated by 
gently mixing the clarified suspension with two volumes of 
cold ethanol (95 percent). The thread-like precipitate 
was collected on a glass rod and dissolved in 20 ml of dil-
ute saline-citrate (lilO dilution of 0.15 M NaCl-0.015 M 
trisodium citrate, pH 7.0), followed by the addition of 2.2 
ml of acetate-EDTA (J.O M sodium acetate-0.001 Ivi EDTA, pH 
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7.0). Ribonuclease (600 µg/ml), previously heated for 10 
minutes at 8o 0 c, was added to the dissolved nucleic acid to 
give a final concentration of 50 µg/ml. The suspension was 
placed at 37°c for JO minutes. The digest was cooled and 
mixed with an equal volume of water-saturated p11.enol and 
shaken for 10 minutes in an ice bath (below 4°c). The sus-
pension was again separated by centrifugation (650 X g for 
10 minutes) and the upper phase clarified (16,300 X g for 
10 minutes) •. DHA was again precipitated by gently mixing 
two volumes of cold ethanol (95 percent) with the suspen-
sion; the DNA was collected on a glass rod and dissolved 
in 20 ml of the dilute saline-citrate and 2.2 ml of acetate-
EDTA for the complete elimination of RNA. While the solu-
tion was rapidly stirred, 0.54 volumes of isopropanol was 
added slowly, and the DNA precipitate was collected with a 
glass rod. The RNA elimination procedure was repeated once 
more using only one-half of the required volumes in the pre-
cipitation. DNA was then stored in ethanol (95 percent) at 
4°c until used. 
Stock solutions of DNA were prepared by dissolving DNA 
in saline-citrate and storing at 4°c. DllA concentration 
was determined by using a nomograph (distributed by Califor-
nia Corporation for Biochemical Research 3625 i·ledford St., 
Los Angeles 63, California) and the DNA absorbance ratio at 
260-280 nm. 
DNA Thermal Denaturation Studies 
Thermal denaturation studies of f. fluorescens DNA, 
isolated as described above, were performed using the pro-
cedure of Kerr (1963). Tubes containing DNA and DNA plus 
the test compounds were prepared in a total volume of 2.5 
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ml of saline-citrate (0.15 M NaCl-0.015 !Vi trisodium citrate, 
pH 7.0). These mixtures were incubated JO minutes at 37°c. 
An equal volume of methanol (2.5 ml) was added to each tube 
which was shaken thoroughly; the tube was plugged with a 
rubber stopper. Thermal denaturation temperatures were 
reached by heating the DNA-containing mixtures and the appro-
priate controls in a laboratory water bath. When the de-
sired temperature was attained, a 7 minute temperature e-
quilibration period was observed. The tubes were removed 
from the water bath and placed in an ice bath for 5 minutes. 
Absorbancies were read on the Beckman DU Spectrophotometer 
at 260 nm and an absorbance ratio was calculated by dividing 
the absorbance at 260 nm of each temperature by the initial 
absorbance 260 nm at 37°c. 
DNA Dialysis Procedure 
DNA plus the appropriate combinations of compounds to 
be tested were prepared in saline-citrate buffer. These 
mixtures were then placed in dialysis tubing and dialyzed 
against 4 liters of saline-citrate buffer for the prescri-
bed time intervals at 4°c with constant stirring and with 
the buffer changed at 24 hour intervals. After the dialy-
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sis was complete, the samples were removed from the tubing 
for use in denaturation studies or in UV spectrophotometric 
studies. 
Spectrophotometric Studies 
The ultraviolet absorption spectra of aqueous solu-
tions containing the prescribed concentrations and combina-
tions of compounds were conducted using a Cary 14 recording 
spectrophotometer at room temperature in 1 centimeter light 
path quartz cuvettes. 
CHAPTER III 
RESULTS AND DISCUSSI01~ 
Amidase Synthesis by Cells Grown in 
Different Carbon Sources 
Cells were grown in succinate-salts medium plus acet-
amide and acetamide-salts medium, and enzyme production was 
measured in the two media (Fig. 5). The enzyme production 
pattern of cells grown in the acetamide-salts medium was 
characteristic of that described by Ferguson (1970). A di-
phasic induction pattern for amidase synthesis was observed. 
Kelly and Kornberg (1962) also reported a similar induction 
pattern in acetamide-salts medium. They-proposed that phase 
I of the enzyme synthesis prior to the plateau was due to 
induction by acetamide. This phase was complete when the 
acetamide content of the medium dropped to a low level. 
Phase II, the rapid initiation of enzyme synthesis follow-
ing the plateau, occurred during subsequent growth on the 
acetate that was formed during the hydrolysis of acetamide. 
The induction pattern of cells grown in the succinate-salts 
plus acetamide medium, compared to the cells with acetamide 
as the sole carbon source, did not exhibit the diphasic in-
duction pattern. 
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Figure 5. Comparison of Amidase Synthesis by P. fluorescens 
Grown in Media with Two Different Carbon Sour-
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The quicker production of enzyme by cells grown in 
acetamide as the carbon source probably resulted from the 
cells immediate need for enzyme to utilize the acetamide 
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for growth. Cells grown with succinate as carbon source and 
acetamide as inducer had no immediate need for the acetamide, 
and thus did not begin synthesizing the enzyme until the 
succinate carbon source was exhausted. These results are 
consistent with those reported by Brammer and Clarke (1964), 
that some tricarboxylic acid intermediates acted as repres-
sors of amidase synthesis. 
Comparison of Actinomycin D Inhibition 
of Amidase Synthesis by Cells Grown 
in Two Different Carbon Sources 
The actinomycin D inhibition of amidase synthesis of 
cells grown in succinate-salts plus acetamide medium and 
acetamide-salts medium was followed to compare the sen-
sitivity of enzyme synthesis to actinomycin D in cells 
grown in the presence of different carbon sources. Actin-
omycin D (in concentrations of 0.004 µg/ml, 0.04 µg/ml, 0.4 
µg/ml, and 4.0 µg/ml) was added to cells growing in the two 
different media. In the succinate-salts medium, amidase 
synthesis was inhibited only 3% by a concentration of o.4 
µg/ml of actinomycin D, while in the acetamide-salts medium, 
actinomycin D (at a concentration of 0.04 µg/ml) gave 6% 
inhibition of amidase syntheais. This may occur because of 
the additional carbon source in the succinate-salts plus 
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acetamide medium, resulting in the requirement for higher 
concentrations of actinomycin D to inhibit amidase synthe-
sis (Table I). Actinomycin D at much smaller concentrations 
inhibited amidase synthesis in the acetamide-salts medium, 
possibly due to only one carbon source being available or a 
change in the cells permeability to actinomycin D, allowing 
smaller concentrations of actinomycin D ~o inhibit the cells. 
Thus, higher concentrations of actinomycin D were required 
to inhibit amidase synthesis in succinate-salts plus acet-
amide than acetamide-salts medium. 
TABLE I 
PERCENT INHIBITION OF ENZYME SYNTHESIS 
BY DIFFERENT CONCENTRATIONS 
OF ACTINOMYCIN D 
Concentration of Succinate-Sal ts Acetamide-Salts 
Actinom;ycin D Medium Medium 
0.004 µg/ml 0% 0% 
0.04 µg/ml 0% 6% 
o.4 µg/ml 3~; 32% 
4.o µg/ml 100% 100% 
In the following experiments involving the amidase 
system, succinate-salts plus acetamide medium will be used 
because a diphasic induction pattern does not occur, mak-
ing it easier to interpret the results. Also higher con-
centrations of actinomycin D can be used in the experiments. 
In experiments requiring a non-inhibitory concentration of 
actinomycin D, o.4 µg/ml was used, and a concentration of, 
4.0 µg/ml was used as an inhibitory concentration. 
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An experiment was conducted to determine if actinomycin 
D was inhibiting the actual synthesis of the enzyme itself 
or possibly acting on the amidase enzyme to inactivate it. 
The latter would make it impossible to assay for the enzyme 
even if it was synthesized by the cells. Cells were allowed 
to grow in succinate-salts plus acetamide medium, and, at 5 
hours, actinomycin D at a concentration of 4.o µg/ml was ad-
ded. Actinomycin D added after 5 hours inhibited enzyme 
synthesis only a small amount. Actinomycin D added at time 
zero completely inhibited enzyme synthesis (Figure 6). The 
cells in which actinomycin D was added at 5 hours had begun 
to synthesize the enzyme for which an assay was made. The 
results indicated that the presence of actinomycin D did not 
inactivate the enzyme already present, but had begun to in-
hibit the synthesis of it. 
Potentiation of Actinomycin D by the 
Hydroxypyrazole in Succinate-
Sal ts Plus Acetamide Medium 
The effect of the hydroxypyrazole on amidase synthesis 
was studied by adding different concentrations of the hy-
droxypyrazole to the cells. Amidase synthesis by P. fluo-
rescens in (succinate, glucose, or acetamide)-salts medium 
was not affected by the hydroxypyrazole at a maximum con-
centration of JO µg/ml. 
Figure 6. Effects of Actinomycin D on the Activity of the 
Amidase Enzyme.41, succinate-salts plus aceta-
mide control;~, actinomycin D, 4.0 pg/ml;~, 
actinomycin D, 4 µg/ml added at 5 hours. 
en .... 
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An interesting phenomenon occurred when the hydroxy-
pyrazole and actinomycin D were combined. The action of 
actinomycin D, at 0.4 µg/ml (a subinhibitory concentration) 
was potentiated by the hydroxypyrazole at 20 µg/ml. The 
compounds separately at these concentrations had no effect 
upon amidase synthesis, but in combination, a 50% inhibition 
of amidase synthesis was observed (Fig. 7). Chesnut et al. 
(1974) provided proton-magnetic-resonance and ultraviolet 
spectroscopic evidence for a molecular complex between ac-
tinomycin D and the hydroxypyrazole. The potentiation of 
actinomycin D by the hydroxypyrazole was postulated by Ches-
nut et al. (1974) to occur via a complex between the two 
compounds rather than the hydroxypyrazole potentiating ac-
tinomycin D by acting at the membrane and allowing quicker 
entry of actinomycin D into the cells. 
Experiments were next conducted to investigate the hy-
droxypyrazole' s mechanism of potentiating actinomycin D. 
Cells were grown in the presence of the hydroxypyrazole at 
a concentration of 20 pg/ml, which is the same concentra-
tion used in the potentiation experiment. The cells were 
allowed to grow for 12 hours, were then washed in O.OlM 
phosphate buffer (pH 7.0) and were resuspended in succinate-
sal ts plus acetamide medium. Actinomycin D was added to 
give a final concentration of o.4 pg/ml. Amidase synthesis 
by these cells was followed to determine if potentiation of 
a subinhibitory concentration of actinomycin D occurred. 
Potentiation did not occur, indicating that the ability of 
Figure ?. Potentiation of Actinomycin D by the Hydroxy-
pyrazole in Succinate-Salts plus Acetamide 
lVIedium.e, succinate-salts plus acetamide 
control and hydroxypyrazole, 20 µg/ml;~, 
actinomycin D, o.4 µg/ml;~, actinomycin D, 
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the hydroxypyrazole to potentiate actinomycin D action does 
not result from the hydroxypyrazole alone (Table II). Po-
tentiation of actinomycin D most likely occurred when the 
two compounds combined, perhaps as the complex proposed by 
Chesnut et al. (1974). 
TABLE II 
INHIBITION OF ENZYME SYNTHESIS RESULTING 
FROM ALTERNATING GROWTH OF CELLS IN 








( 20 µg/ml) 
Actinomycin D 




( 20 µyml) 
0% 
44% 
The previous experiment was conducted to examine the 
action of the hydroxypyrazole and actinomycin D by adding 
actinomycin D to hydroxypyrazole grown cells. This proce-
dure was reversed, and the hydroxypyrazole was added to cells 
grown in the presence of 0.4 µg/ml of actinomycin D. The 
cells were allowed to grow for 12 hours in the presence of 
actinomycin D, were washed in O.OlM phosphate buffer and 
were suspended in succinate-salts plus acetamide medium. 
The hydroxypyrazole was added to give a final concentration 
of 20 µg/ml. Amidase synthesis was again followed. How-
ever, potentiation did occur when the cells were exposed to 
to the hydroxypyrazole (Table II). This lends support to 
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the hypothesis that the hydroxypyrazole is not potentiating 
actinomycin D by altering the cell permeability to allow 
quicker passage of actinomycin D into the cell,. but instead 
it may occur via a complex between the two compounds. 
Potentiation of Actinomycin D Activity 
by the Hydroxypyrazole in Glucose-
Sal ts Plus Acetamide Medium 
The degree of sensitivity of P. fluorescens to actino-
mycin D varies significantly depending on the carbon source 
in which the organism is growing. Cells grown in succinate 
exhibit pronounced sensitivity to actinomycin D when compar-
ed with glucose grown cells (Walker and Durham, 1975). Ex-
periments were conducted to determine if the cells ability 
to synthesize amidase in the presence of actinomycin D or 
the combination of actinomycin D and the hydroxypyrazole was 
altered when the cells were grown in glucose-salts plus a-
cetamide medium. 
Amidase synthesis was followed by the same procedure 
as in previous experiments except the. carbon source in the 
growth medium was changed. Enzyme production of cells with 
glucose as their carbon source was much quicker than with 
cells with succinate as the carbon source. That is, enzyme 
formation began after 2 hours of growth with glucose as com-
pared to 4 hours required when succinate grown cells syn-
thesized amidase. The overall quantity of enzyme produced 
by glucose grown cells was smaller, however, than that pro-
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ducod by succirrate grown cells (Fig. 6). 
foter:tiation of actinoinycin D at a co~'1centra tioc of 
O. L1. pg/ml ty the hydroxypyrazole and with a concentration 
of 20 )Jg/1;il. for glucose as the carbon source could not be 
de~onstrated. An experi~ent was conducted with actinomycin 
D concentrations increased from 0.4 pg/ml to 1.2 and 1.6 pg/ 
ml and the hydroxypyrazole concentration was 20 µg/:nl (F'ig. 
9). At these concentrations, potentiation of actinomycin 
D could be demonstrated in cells grown with glucose as the 
car bot' :.: ource. 
Jalker and Durham (1975) established that glucose-
~o:rown ccdl0 ~1ave a higher concentration of lipopolysaccha-
ride than succinate-grown cells, which may influence the 
permeability of the cells to actinomycin D. 1rhe higher con-
centration of actinomycin D required to demonstrate poten-
tiation may possibly be explained by a decrease in permea-
bility of the Glucose grown cells to actinomycin D due to 
an increased amount of lipopolysaccharide. 
'ri:ne Reouirement for Acti~o;nycin D-
iiydroxypyrazole Complex Formation 
The proposed interaction of actinomycin ~ and the hy-
droxypyraz ole was investi,:;ated to determine the time require-
ment for cornplex formation. Amidase synthesis by f. fluo-
_[§_scens was followed as previously described. Actinomycin 
D at a concentration of o.4 µg/ml and hydroxypyrazole at 20 
µg/ml were combined and incubated (at room temperature) for 
Figure 8. Comparison of Amidase Synthesis by f. fluo-
rescens Grown in Succinate-Salts plus acet-
amide and Glucose-Sal ts plus Acetamide. e, 
succinate-salts plus acetamide;(), glucose-
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Figure 9, Potentiation of Actinomycin D by the Hydroxy-
pyrazole in Glucose-Salts plus Acetamide 
Medium.e, glucose-salts plus acetamide 
control and hydroxy»yrazole, 20 µg/ml;~, act-
inomycin D, 1.2 µg/ml;ll, actinomycin D, 1.6 
µg/ml;l)., actinomycin D, 1.2 µg/ml plushy-
droxypyrazole, 20 µg/ml;[], actinomycin D, 
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1 hour before addition to the culture flasks. The combina-
tion of the compounds incubated for 1 hour did not demon-
strate an increased potentiation effect of actinomycin D as 
might be expected if the complexation of the compounds was 
not immediate. The same amount of amidase inhibition occur-
red if the compounds were incubated for 1 hour or added sim-
ultaneously to the culture flask at the beginning of the ex-
periment. Results from this type of experimentation indi-
cated that the complex formation probably occurred immedia-
tely between the two compounds, 
Effect of the Hydroxypyrazole 
on Mitomycin C 
It has been reported that the hydroxypyrazole demon-
strates an action on sheep red blood cells and Bacillus 
subtilis protoplasts. The hydroxypyrazole also potentiates 
polymyxin and circulin, which are membrane active antibio-
tics. The action of mitomycin C was not potentiated by the 
hydroxypyrazole in experiments using sheep red blood cells 
and B. subtilis protoplasts (Haslam, 197.3). 
The lack of potentiation of mitomycin C by the hydroxy-
pyrazole reported by Haslam (1973) was investigated using 
the inducible enzyme system. Concentrations of o.025µg/ml 
and 0.05 pg/ml of mitomycin C were used with a hydroxypyra-
zole concentration of 20 µg/ml. Enzyme production was fol-
lowed as before to check for a possible potentiation of mi-
tomycin C by the hydroxypyrazole. Figure (10) illustrates 
Figure 10. Effects of the Hydroxypyrazole on Mitomycin C 
Inhibition of Amidase Synthesis.e, succinate-
salts plus acetamide control and hydroxypyra-
zole, 20 ,ug/ml; •, mi tomycin C, 0. 025 µg/'ml; 
/::::,., mitomycin C, 0,025 ).lg/ml plus hydroxy-
pyrazole, 20 ,ug/ml;ll, mitomycin C, 0.05 ,ug/ 
ml;[J, mitomycin C, 0.05 pg/ml plus hydroxy-
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the results from the experiment. The combinations of mito-
mycin C and the hydroxypyrazole gave the same amount of en-
zyme inhibition as mitomycin C alone. 
Results from this experiment support the finding of 
Haslam (1973) that the action of mitomycin C was not poten-
tiated by the hydroxypyrazole. The lack of potentiation of 
mitomycin C may result from the lack of adequate complexa-
tion of the antibiotic with the hydroxypyrazole. 
Reversal of Enzyme Inhibition 
by Protocatechuate 
Ferguson (1970) established that protocatechuate would 
prevent and/or reverse actinomycin D inhibition of growth 
and amidase synthesis by P. fluorescens. Durham and Fergu-
son (1971) established that J,4-dihydroxybenzoate (protocat-
echuate) was the most effective of the dihydroxybenzoate 
analogs in preventing and/or reversing the actinomycin D 
inhibition of amidase synthesis. Experiments were conducted 
to determine if protocatechuate had the potential to also 
reverse the potentiation of actinomycin D by the hydroxy-
pyrazole. 
The prevention of actinomycin inhibition was reestab-
lished by following amidase synthesis of cells in the pre-
sence of an inhibitory concentration of actinomycin D and 
of cells in the presence of the inhibitory concentration 
of actinomycin D plus protocatechuate all added simultan-
eously to the culture flask. The results indicate (Fig. 11) 
Figure 11. Reversal of Actinomycin D Inhibition of Amidase 
Synthesis by Frotocatechuate. e, succinate-
sal ts plus acetamide control and protocate-
chuate, 120 pg/ml;., actinomycin D, 4.0 pg/ 
ml plus protocatechuate, 120 pg/ml;~, actino-
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that protocatechuate does possess the ability to prevent 
the inhibition of amidase synthesis. 
Actinomycin D was combined with the hydroxypyrazole 
46 
and protocatechuate to determine if protocatechuate was a-
ble to prevent the potentiation effect of the hydroxypyra-
zole on actinomycin D. The appropriate controls and com-
bination of the compounds were added to the cultures simul-
taneously and amidase synthesis was followed (Fig. 12). 
The results from this experiment indicate protocatechuate 
has the ability to prevent inhibition of actinomycin D which 
is potentiated by the hydroxypyrazole. 
Experiments were also conducted which indicated that 
protocatechuate could not only prevent, but also reverse 
the inhibition of actinomycin D potentiated by the hydroxy-
pyrazole, This was done by allowing the cell cultures to 
incubate with the combination of actinomycin D and t~ hy-
droxypyrazole for 2 hours before adding protocatechuate to 
the culture flasks. After addition of protocatechuate to 
the cultures, enzyme synthesis resumed at a normal level 
with about a 2 hour lag in the synthesis. 
A possible interaction occurring between the three 
compounds via a trimember complex was next investigated by 
examining thermal denaturation of P. fluorescens DNA. 
Figure 12. Reversal of Actinomycin D-Hydroxypyrazole 
Inhibition of Amidase Synthesis by Proto-
ca techua te. tt, succinate-salts plus acet-
amide control and hydroxypyrazole, 20 pg/ml, 
and protocatechuate, 120p.g/ml; .. , actinomy-
cin D, 0,4 .)lg/ml ;8, actinomycin D, 0.4 JJ,g/ml 
pl us hydroxypyrazole, 20 ..ug/ml ;. , actinomy-
cin D, 0,4,,ug/ml plus hydroxypyrazole, 20 
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Interactions of Actinomycin D, Hydroxy-
pyrazole, and Protocatechuate with DNA 
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It has been well established that actinomycin D has a 
primary site of action at the DNA level within a cell (Kirk, 
1960). Evidence from earlier work (Haslam, 1973: .Ferguson, 
1970) indicated that possible complexation occurred between 
the hydroxypyrazole and actinomycin D, and between protocat-
echuate and actinomycin D. If a complexation of hydroxypy-
razole and protocatechuate occurred with actinomycin D, 
which has a site of action at the DNA level, the hydroxypy-
razole and protocatechuate may also possess a site of action 
at the DNA level. 
A thermal denaturation experiment was conducted using 
F. fluorescens DNA as a control, and with DNA, at a concen-
tration of 20 µg/ml, singly combined with actinomycin D at 
20 µg/ml, hydroxypyrazole at 4pg/ml, and protocatechuate 
at 20 µg/ml, to determine if the 8ompounds individually 
would bind to or otherwise influence the thermal melting of 
DNA. Individually, all three compounds caused a shift in 
the DHA melting curve to higher temperatures. Actinomycin 
D and the hydroxypyrazole alone demonstrated approximately 
the same melting curve with a 5°c increase in thermal dena-
turation temperature. Protocatechuate demonstrated the 
greatest shift in the melting curve with a io 0 c increase in 
thermal denaturation temperature (Fig. 13). Results from 
the experiment indicated that actinomycin D binds to DNA, 
Figure 13. Effect of Actinomycin D, Hydroxypyrazole, and 
Protocatechuate Upon Thermal Denaturation 
of P. fluorescens DNA. e, control DNA, 20 
pg/ffil; .A., DNA and actinomycin D, 20 ,..ug/ml, 
DNA and hydroxypyrazole, 4. O .,ug/ml; 0, DNA 
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and both the hydroxypyrazole and protocatechuate also have 
the potential to bind or interact with DNA. 
Effects of Combinations of 
Compounds Upon DNA 
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The combination of the hydroxypyrazole with actinomycin 
D potentiated the inhibitory effect of actinomycin Das de-
monstrated in the amidase experiments. Protocatechuate was 
shown by the same method to reverse or prevent the inhibi-
tion of the combination of actinomycin D and the hydroxypy-
razole, or the inhibition caused by actinomycin D alone. 
The effects of the three combinations of compounds upon 
DNA was next investigated. The thermal denaturation of P. 
fluorescens DNA was used as the test system. Combinations 
used to react with DNA werea hydroxypyrazole and actinomy-
cin D; actinomycin D, protocatechuate, and hydroxypyrazole. 
Both combinations of compounds produced a shift in the melt-
ing curve. Actinomycin D and hydroxypyrazole in combination 
increased the thermal denaturation end point 9°c. The ther-
mal denaturation end point for the combination of actinomy-
cin D,hydroxypyrazole and protocatechuate could not be det-
ermined since only a small change was observed at tempera-
tures as high as s5°c (Fig. 14). 
The shifts.in melting curves of DNA with the trimember 
combination of compounds was greater than the shifts in the 
curve caused by each compound separately (Fig. 15). The 
combinations of all three compounds shifted the DNA melting 
Figure 14. Effects of Combinations of Compounds Upon 
Thermal Denaturation of P. fluorescens DNA. 
•• control DNA, 20 µg/ml; •, DNA and actino-
mycin D, 20 pg/ml plus hydroxypyrazole, 4.0 
µg/ml;t:._, DNA and actinomycin D, 20)lg/ml 
plus hydroxypyrazole, 4.0 pg/ml plus proto-
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Figure 15. Combination of Figure 13 and 14.~, control 
DNA 20 µg/ml;,&, DNA and actinomycin D, 
20 pg/ml, also DNA and hydroxypyrazole, 4.o 
pg/ml;(), DNA and protocatechuate, 20 ,Pg/ml; 
•, DNA and actinomycin D, 20 µg/ml plus hy-
droxypyrazole, 4.o µg/ml;~, DNA and actino-
mycin D, 20 µg/ml plus hydroxypyrazole, 4.o 
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curve the greatest. The combination of the three compounds 
almost completely stabilized the DNA helix since only a 
small amount of thermal denaturation occurred. A 4°c in-
crease in thermal denaturation temperature occurred with the 
combination of actinomycin D and hydroxypyrazole compared to 
the two compounds used individually. This increase in tem-
perature and the complete stabilization of the DNA helix by 
all three compounds may support the hypothesis that the com-
pounds are complexing and demonstrating new properties, 
Several experiments were conducted in which the order 
of addition of the compounds to DNA was changed. This type 
of experiment was conducted to determine if there was any 
type of competition for the same binding site on DNA. One 
of the compounds was added to DNA and all.owed to incubate 
(at room temperature) for ten minutes; the other compounds 
were added to the mixture, and thermal denaturation experi-
ments were then conducted (Table III), Different combina-
tions of addition sequences were tested and no correlations 
could be found between the addition sequence of the compounds 
and any effects upon thermal denaturation of DNA. The res-
ults seem to indicate that competition between the compounds 
for a specific binding site on the DNA helix was not occur-
ring. This may support the hypothesis that the compounds 
were complexing. However, at this time, interpretation of 
these results remains unclear. 
Earlier it was noted that P. fluorescens was more re-
sistant to actinomycin D when grown in a medium containing 
glucose as the carbon source, The reason for this resis-
tance of the cells grown in glucose medium was believed to 
be due to more lipopolysaccharide being synthesized by the 
cells, which would decrease the cells permeability to act-
inomycin D. However, to determine if there might be some 
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difference in DNA of glucose and succinate-grown cells, the 
following study was conducted. 
TABLE III 
THERMAL DENATURATION RESULTS FROM 
SEQUENCING THE COMPOUNDS 
ADDITION TO DNA 
Compounds Added Compound Added After Thermal Denatur-
Initially 10 Minutes ation Endpoint 
Actinomycin D 
( 20 µg/ml) None 74°c Hydroxypyrazole 
( 4 µg/ml) 
Actinomycin D 
( 20 µg/ml) 
Hydroxypyrazole 




( 20 µg/ml) ?4°c 
Actinomycin D 
( 20 pg/ml) None 76°c Protocatechuate 
( 20 µg/ml) 
Actinomycin D Protocatechuate 
?6°c ( 20 µg/rnl) ( 20 µg/ml) 
Protocatechuate Actinomycin D 
?6°c ( 20 ,ug/ml) ( 20 ,ug/ml) 
A thermal denaturation experiment was performed with 
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DlJA isolated from f · fluorescens cells grown in glucose-
sal ts medium to explore the possibility of a change in DNA 
which might alter the compounds binding. The same experi-
mental procedure was followed as in earlier experiments only 
using DNA from glucose grown cells. The same melting cur-
ves were obtained in this experiment with DNA from glucose 
grown cells as those of DNA from succinate grown cells. 
The results obtained indicated that the resistance to actin-
omycin D was not a result of changes occurring at the DNA 
level but probably at the permeability barrier. 
Dialysis of Compounds and DNA Prior 
to Thermal Denaturation 
Protocatechuate has demonstrated the ability to pre-
vent and/or reverse inhibition of amidase by actinomycin D 
or a combination of actinomycin D and the hydroxypyrazole. 
Durham and Ferguson (1971) proposed that actinomycin D com-
plexes with DNA and is reversed by protocatechuate. That 
is, actinomycin D has a greater affinity for the protocate-
chuate molecule than the DNA helix• thus protocatechuate 
may act by combining with actinomycin D at such time as the 
antibiotic comes off the DNA helix. An experiment was con-
ducted to investigate the possibility of protocatechuate de-
creasing the affinity of actinomycin D and the complex of 
actinomycin D-hydroxypyrazole for the DNA helix. 
The same volumes and concentrations of the compounds 
used in the thermal denaturation studies were combined with 
Di1JA, which will not pass through the dialysis tubing, and 
each combination placed in separate dialysis tubes. The 
samples were allowed to dialize for 72 hours in saline-
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ci tra te buffer, pH 7.0, and then removed from the dialysis 
tubing and used in thermal denaturation experiments. Act-
inomycin D, hydroxypyrazole, and protocatechuate combined 
singly with DFA exhibited the same DNA melting curve as the 
control, indicating that they were removed sufficiently by 
the dialysis. The combination of actinomycin D and protoca-
techuate also exhibited the same DNA melting curve as the 
control, again indicating any complex they form with DNA is. 
reversible. Actinomycin D and the hydroxypyrazole after 
dialysis gave about the same DNA melting curve, which was 
demonstrated before dialysis, indicating the complex which 
formed with DNA was not reversible. The combination of all 
three compounds increased the thermal denaturation end 
point 7°c above the control, but the increase in thermal 
denaturation was not as great as before dialysis at which 
time the three compounds individually almost completely in-
hibited DNA denaturation (Fig. 16). 
'rhis experiment attempted to show a correlation be-
tween the compounds movement out of the dialysis tube and 
their affinity for the DNA helix. Results from the experi-
ment indicate that the combination of actinomycin D and the 
hydroxypyrazole together had a greater affinity for DNA than 
the combination of the two compounds plus protocatechuate. 
'rhe ability of protocatechuate to prevent and/or reverse 
Figure 16. Effect of the Compounds Upon Thermal Denatura-
tion of P. fluorescens DNA after 72 Hours of 
Dialysis7e, control DNA, 20µg/ml, also DNA 
and actinomycin D, 20 µg/ml, also DNA and hy-
droxypyrazole, 4.0 µg/ml, also DNA and proto-
catechuate, 20 µg/ml, also DNA and actinomy-
cin D, 20 pg/ml plus protocatechuate, 20 ;;.g/ 
ml;~, DNA and actinomycin D, 20 )lg/ml plus 
hydroxypyrazoliie 4.o µg/ml plus protocatechu-
ate, 20 ;;.g/ml; , DNA and actinomycin D, 20 





















the inhibition e:ffects of the combination of actinomycin D-
hydroxypyrazole may possibly be occurring by protocatechuate 
interacting with actinomycin D and the hydroxypyrazole to 
form a complex with m~A which is reversible. 
Further dialysis experimentation was conducted with the 
compounds and combinations used at the same concentrations 
as in the previous experiment but in the absence of DNA. 
This type of e:x;periment attempted to show that complexes 
of these compounds would pass through dialysis tubing slow-
er than the individual compounds. The compounds were placed 
in dialysis tubing and allowed to dialyze up to 24 hours. 
Samples were taken at 2 hour intervals and scanned in the 
spectrophotometer. The shorter time period was used because 
the compounds passed out of the dialysis tubing much quick-
er when DNA was not present. The interpretation of the spec-
tral results from this experiment was somewhat unclear and 
no conclusion could be drawn. 
CHAPTER IV 
SUMIVIARY AND CONCLUSIONS 
The enzyme induction pattern of £. fluorescens was 
shown to be distinctly different when cells were grown in 
media containing different carbon sources. The sensitivity 
of the enzyme system to actinomycin D also changed depend-
ing on the carbor. source in which the cells were grown. 
Inhibition of enzyme synthesis was greatest in cells grown 
with acetamide as the carbon source followed by less inhi-
bition with succinate grown cells. The least inhibition was 
with glucose grown cells being the most resistant to actin-
omycin D. 
The reasons for these differences in sensitivity to 
actinomycin D were probably not the results of changes at 
the DNA level within the cells. This conclusion was based 
on the lack of a difference in temperatures of denaturation 
for DNA isolated from glucose-grown cells or succinate-
grown cells when the test compounds were present. Thus the 
difference in sensitivity likely resulted from changes in 
the lipopolysaccharide of the cells grown in media with a 
different carbon source which in turn changes the cells per-
meability to actinomycin D. 
A complexation between actinomycin D and the hydroxy-
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pyrazole which probably occurred instantly was observed in 
this investigation. When these two compounds were mixed 
together, the proposed complex was allowed to form, and a 
definite potentiation effect upon actinomycin D occurred, 
which was demonstrated by the amidase system. Experiments 
conducted by growing the cells in the presence of one com-
ponent of the complex, and then adding the other after thor-
ough washing of the cells, gives support to a complexation 
occurring between actinomycin D and the hydroxypyrazole, 
causing the potentiation effect (Fig. 17). 
The ability of the hydroxypyrazole to potentiate act-
inomycin D was demonstrated in both succinate-salts plus 
acetamide and glucose-salts plus acetamide media. The hy-
droxypyrazole however was not capable of potentiating mito-
mycin c. The lack of an active complex formation could be 
the possible reason for this, since there is a definite dif-
ference in mitomycin C and the structure of actinomycin D. 
This inability of the hydroxypyrazole to potentiate mito-
mycin C indicated that the potentiation of actinomycin D is 
not coming from some type of action at the surface of the 
cell for if this was true it should have potentiated mito-
mycin C. 
It was demonstrated in the amidase system that proto-
ca techua te could be added simultaneously with actinomycin D 
or the combination of actinomycin D and the hydroxypyrazole 
or after inhibition was partially established to prevent 
and/or reverse the inhibitory effects. 
Figure 17. Proposed Model of Actinomycin D-Hydroxypyrazole 
Complexation. This is an illustrative model 
of the complex formation between actinomycin D 
and the hydroxypyrazole. Chesnut et al. (1974) 
provided evidence that the complex is stabil-







c =-d / .. .. / 
NH 





Thermal denaturation conducted with_P. fluorescens DNA 
and the compounds demonstrated that all three compounds in-
teract with Dl'JA to stabilize the DNA helix, resulting in a 
shift of the DNA melting curve to high temperatures. vlhen 
the compounds are combined together the combination of act-
inomycin D and the hydroxypyrazole shifts the DNA melting 
curve a greater amount than either compound alone. The 
combination of all three compounds almost completely stab-
ilized the DHA up to thermal denaturation temperatures of 
s5°c. The ability of the three compounds, combined together, 
to cause an increased amount of DNA stabilization may be 
the result of a three-member complex between actinomycin D, 
hydroxypyrazole, and protocatechuate. 
A possible mechanism partially explaining the ability 
of protocatechuate to reverse the inhibition effects of 
actinomycin D combined with the hydroxypyrazole in the ami-
dase system was postulated. Protocatechuate may be inter-
acting with actinomycin D and the hydroxypyrazole to cause 
a complexation of three compounds with DNA which is revers-
ible. This was supported by the dialysis experiment in 
which the combination of all three compounds was dialyzed 
off of DNA quicker than the combination of actinomycin D 
and the hydroxypyrazole. This would indicate that proto-
catechuate is altering the compounds affinity for the DNA 
helix by possibly forming a three-member complex with actin-
omycin D and the hydroxypyrazole. 
In conclusion, this investigation demonstrates that 
some type of interaction is occurring between the three 
compounds. The results from the enzyme system and thermal 
denaturation studies point to a three-member complexation 
between actinomycin D, hydroxypyrazole and protocatechuate 
which may allow protocatechuate to prevent and/or reverse 
inhibition of amidase synthesis by actinomycin D potentia-
ted by the hydroxypyrazole. 
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